Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 341724, 14 pages
http://dx.doi.org/10.1155/2013/341724
Research Article

Cytotoxicity and Pharmacogenomics of Medicinal Plants from Traditional Korean Medicine

1Department of Biochemistry, Faculty of Science, University of Dschang, Cameroon
2Department of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, Johannes Gutenberg University, Staudinger Weg 5, 55128 Mainz, Germany
3HanseMerkur Center for Traditional Chinese Medicine, University Hospital Eppendorf, Hamburg, Germany
4Biomedical Sciences Institute Abel Salazar, University of Porto, Portugal
5Heidelberg School of Chinese Medicine, Heidelberg, Germany
6College of Pharmacy, Chonnam National University, Gwangju, Republic of Korea

Received 25 March 2013; Accepted 24 April 2013

Academic Editor: Sookyung Lee

Copyright © 2013 Victor Kuete et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Lee, H. S. Lillehoj, H. Chun et al., “In vitro treatment of chicken peripheral blood lymphocytes, macrophages, and tumor cells with extracts of Korean medicinal plants,” Nutrition Research, vol. 27, no. 6, pp. 362–366, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. D. S. Bhakuni, M. Bittner, C. Marticorena et al., “Screening of Chilean plants for antimicrobial activity,” Lloydia, vol. 37, no. 4, pp. 621–632, 1974. View at Google Scholar · View at Scopus
  3. N. R. Farnsworth, O. Akerele, and A. S. Bingel, “Medicinal plants in therapy,” Bulletin of the World Health Organization, vol. 63, no. 6, pp. 965–981, 1985. View at Google Scholar · View at Scopus
  4. C. Stévigny, C. Bailly, and J. Quetin-Leclercq, “Cytotoxic and antitumor potentialities of aporphinoid alkaloids,” Current Medicinal Chemistry, vol. 5, no. 2, pp. 173–182, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. D. J. Newman and G. M. Cragg, “Natural products as sources of new drugs over the last 25 years,” Journal of Natural Products, vol. 70, no. 3, pp. 461–477, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. S. Cheong, E. W. Park, S. M. Yoo et al., “Use of traditional medicine and folk remedies in hypertensive patients: based on Cheonan practice-based research network,” Journal of the Korean Academy of Family Medicine, vol. 19, no. 2, pp. 141–149, 1998. View at Google Scholar
  7. C. D. Hong, “Complementary and alternative medicine in Korea: current status and future prospects,” Journal of Alternative and Complementary Medicine, vol. 7, supplement 1, pp. S33–S40, 2001. View at Google Scholar · View at Scopus
  8. M. S. Hong, K. H. Chun, H. J. Song, and I. W. Park, “Attitudes towards complementary and alternative medicine in Suwon city,” Korean Journal of Preventive Medicine, vol. 32, no. 2, pp. 162–169, 1999. View at Google Scholar
  9. G. A. Cordell, C. W. W. Beecher, and J. M. Pezzuto, “Can ethnopharmacology contribute to the development of new anticancer drugs?” Journal of Ethnopharmacology, vol. 32, no. 1–3, pp. 117–133, 1991. View at Google Scholar · View at Scopus
  10. J. Popoca, A. Aguilar, D. Alonso, and M. L. Villarreal, “Cytotoxic activity of selected plants used as antitumorals in Mexican traditional medicine,” Journal of Ethnopharmacology, vol. 59, no. 3, pp. 173–177, 1998. View at Publisher · View at Google Scholar · View at Scopus
  11. J. O'Brien, I. Wilson, T. Orton, and F. Pognan, “Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity,” European Journal of Biochemistry, vol. 267, no. 17, pp. 5421–5426, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. U. Scherf, D. T. Ross, M. Waltham et al., “A gene expression database for the molecular pharmacology of cancer,” Nature Genetics, vol. 24, no. 3, pp. 236–244, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. S. A. Amundson, K. T. Do, L. C. Vinikoor et al., “Integrating global gene expression and radiation survival parameters across the 60 cell lines of the National Cancer Institute Anticancer Drug Screen,” Cancer Research, vol. 68, no. 2, pp. 415–424, 2008. View at Google Scholar · View at Scopus
  14. T. Efferth, U. Fabry, and R. Osieka, “Apoptosis and resistance to daunorubicin in human leukemic cells,” Leukemia, vol. 11, no. 7, pp. 1180–1186, 1997. View at Google Scholar · View at Scopus
  15. K. Wosikowski, D. Schuurhuis, K. Johnson et al., “Identification of epidermal growth factor receptor and c-erbB2 pathway inhibitors by correlation with gene expression patterns,” Journal of the National Cancer Institute, vol. 89, no. 20, pp. 1505–1515, 1997. View at Google Scholar · View at Scopus
  16. Y. J. Hwang, J. Kim, D. S. Park, and K. A. Hwang, “Study on the immunomodulation effect of Isodon japonicus extract via splenocyte function and NK anti-tumor activity,” International Journal of Molecular Sciences, vol. 13, no. 4, pp. 4880–4888, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Son, A. Kim, J. Lee et al., “Ethanol extract of Lycoris radiata induces cell death in B16F10 melanoma via p38-mediated AP-1 activation,” Oncology Reports, vol. 24, no. 2, pp. 473–478, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. X. W. Zhang, C. X. Cui, and L. Y. Chen, “Inhibition of Sorbaria sorbifolia on proliferarion of hepatoma HepG-2 cell line,” Journal of Chinese Medical Materials, vol. 30, no. 6, pp. 681–684, 2007. View at Google Scholar · View at Scopus
  19. J. Boik, Natural Compounds in Cancer Therapy, Oregon Medical Press, Princeton, Minn, USA, 2001.
  20. S. E. Choi, K. H. Kim, J. H. Kwon, S. B. Kim, H. W. Kim, and M. W. Lee, “Cytotoxic activities of diarylheptanoids from Alnus japonica,” Archives of Pharmacal Research, vol. 31, no. 10, pp. 1287–1289, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. H. J. Kim, K. H. Kim, S. H. Yeom et al., “New diarylheptanoid from the barks of Alnus japonica steudel,” Chinese Chemical Letters, vol. 16, no. 10, pp. 1337–1340, 2005. View at Google Scholar · View at Scopus
  22. V. Kuete and T. Efferth, “Pharmacogenomics of Cameroonian traditional herbal medicine for cancer therapy,” Journal of Ethnopharmacology, vol. 137, no. 1, pp. 752–766, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. P. L. Kuo, Y. L. Hsu, T. C. Lin, L. T. Lin, and C. C. Lin, “Induction of apoptosis in human breast adenocarcinoma MCF-7 cells by prodelphinidin B-2 3,3′-di-O-gallate from Myrica rubra via Fas-mediated pathway,” Journal of Pharmacy and Pharmacology, vol. 56, no. 11, pp. 1399–1406, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. G. P. Shnyakina and G. G. Zapesochnaya, “Flavonols and phenolic compounds of Sedum middendorffianum,” Chemistry of Natural Compounds, vol. 9, no. 5, pp. 645–648, 1975. View at Publisher · View at Google Scholar · View at Scopus
  25. Z. L. Sun, Y. Zhang, A. H. Wan, X. L. Zhang, and J. Feng, “A new active compound against kidney deficiency from the fruits of Rubus corchorifolius,” Journal of Asian Natural Products Research, vol. 13, no. 1, pp. 68–74, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. P. T. Thuong, H. J. Kang, M. Na et al., “Anti-oxidant constituents from Sedum takesimense,” Phytochemistry, vol. 68, no. 19, pp. 2432–2438, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. U. S. Harput, Y. Genc, and I. Saracoglu, “Cytotoxic and antioxidative activities of Plantago lagopus L. and characterization of its bioactive compounds,” Food and Chemical Toxicology, vol. 50, no. 5, pp. 1554–1559, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. D. H. Paper, H. Vogl, G. Franz, and R. Hoffmann, “Defined carrageenan derivatives as angiogenesis inhibitors,” Macromolecular Symposia, vol. 99, no. 1, pp. 219–225, 1995. View at Google Scholar
  29. G. R. Pettit, V. Gaddamidi, D. L. Herald et al., “Antineoplastic agents, 120. Pancratium littorale,” Journal of Natural Products, vol. 49, no. 6, pp. 995–1002, 1986. View at Google Scholar · View at Scopus
  30. G. R. Pettit, G. R. Pettit III, R. A. Backhaus, M. R. Boyd, and A. W. Meerow, “Antineoplastic agents, 256. Cell growth inhibitory isocarbostyrils from Hymenocallis,” Journal of Natural Products, vol. 56, no. 10, pp. 1682–1687, 1993. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Mishima, K. Matsumoto, Y. Futamura et al., “Antitumor effect of stilbenoids from Vateria indica against allografted sarcoma S-180 in animal model,” Journal of Experimental Therapeutics and Oncology, vol. 3, no. 5, pp. 283–288, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Sahidin, E. H. Hakim, L. D. Juliawaty et al., “Cytotoxic properties of oligostilbenoids from the tree barks of Hopea dryobalanoides,” Zeitschrift fur Naturforschung C, vol. 60, no. 9-10, pp. 723–727, 2005. View at Google Scholar · View at Scopus
  33. F. Leteurtre, G. Kohlhagen, K. D. Paull, and Y. Pommier, “Topoisomerase II inhibition and cytotoxicity of the anthrapyrazoles DuP 937 and DuP 941 (Losoxantrone) in the National Cancer Institute preclinical antitumor drug discovery screen,” Journal of the National Cancer Institute, vol. 86, no. 16, pp. 1239–1244, 1994. View at Google Scholar · View at Scopus
  34. T. Efferth, A. Olbrich, and R. Bauer, “mRNA expression profiles for the response of human tumor cell lines to the antimalarial drugs artesunate, arteether, and artemether,” Biochemical Pharmacology, vol. 64, no. 4, pp. 617–623, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. T. Efferth, E. Gebhart, D. D. Ross, and A. Sauerbrey, “Identification of gene expression profiles predicting tumor cell response to L-alanosine,” Biochemical Pharmacology, vol. 66, no. 4, pp. 613–621, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Volm, R. Koomägi, J. Mattern, and T. Efferth, “Expression profile of genes in non-small cell lung carcinomas from long-term surviving patients,” Clinical Cancer Research, vol. 8, no. 6, pp. 1843–1848, 2002. View at Google Scholar · View at Scopus
  37. M. Volm, R. Koomägi, J. Mattern, and T. Efferth, “Protein expression profiles indicative for drug resistance of non-small cell lung cancer,” British Journal of Cancer, vol. 87, no. 3, pp. 251–257, 2002. View at Publisher · View at Google Scholar · View at Scopus
  38. C. M. Fillmore, P. B. Gupta, J. A. Rudnick et al., “Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 50, pp. 21737–21742, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. T. R. Burton, T. Kashour, J. A. Wright, and F. M. Amara, “Cellular signaling pathways affect the function of ribonucleotide reductase mRNA binding proteins: mRNA stabilization, drug resistance, and malignancy (Review),” International Journal of Oncology, vol. 22, no. 1, pp. 21–31, 2003. View at Google Scholar · View at Scopus
  40. T. Efferth, V. B. Konkimalla, Y. Wang et al., “Prediction of broad spectrum resistance of tumors towards anticancer drugs,” Clinical Cancer Research, vol. 14, no. 8, pp. 2405–2412, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. K. Wu and B. Bonavida, “The activated NF-κB-snail-RKIP circuitry in cancer regulates both the metastatic cascade and resistance to apoptosis by cytotoxic drugs,” Critical Reviews in Immunology, vol. 29, no. 3, pp. 241–254, 2009. View at Google Scholar · View at Scopus
  42. K. Mahajan and N. P. Mahajan, “PI3K-independent AKT activation in cancers: a treasure trove for novel therapeutics,” Journal of Cell Physiology, vol. 227, no. 9, pp. 3178–3184, 2012. View at Publisher · View at Google Scholar
  43. S. L. Lee, Korea Folk Medicine, Seoul National University Publishing Center Press, Seoul, Republic of Korea, 1996.
  44. S. T. Kim, J. D. Kim, S. H. Ahn, G. S. Ahn, Y. I. Lee, and Y. S. Jeong, “Hepatoprotective and antioxidant effects of Alnus japonica extracts on acetaminophen-induced hepatotoxicity in rats,” Phytotherapy Research, vol. 18, no. 12, pp. 971–975, 2004. View at Publisher · View at Google Scholar · View at Scopus
  45. N. H. Tung, H. Kwon, J. Kim, J. C. Ra, J. A. Kim, and Y. H. Kim, “An anti-influenza component of the bark of Alnus japonica,” Archives of Pharmacal Research, vol. 33, no. 3, pp. 363–367, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. M. W. Lee, T. Tanaka, G. I. Nonaka, and I. Nishioka, “Dimeric ellagitannins from Alnus japonica,” Phytochemistry, vol. 31, no. 8, pp. 2835–2839, 1992. View at Google Scholar · View at Scopus
  47. S. Kim, E. Jung, S. Shin et al., “Anti-inflammatory activity of Camellia japonica oil,” BMB Reports, vol. 45, no. 3, pp. 177–182, 2012. View at Publisher · View at Google Scholar
  48. K. Y. Kim, P. M. Davidson, and H. J. Chung, “Antibacterial activity in extracts of Camellia japonica L. petals and its application to a model food system,” Journal of Food Protection, vol. 64, no. 8, pp. 1255–1260, 2001. View at Google Scholar · View at Scopus
  49. J. C. Park, J. M. Hur, J. G. Park et al., “Inhibitory effects of Korean medicinal plants and camelliatannin H from Camellia japonica on human immunodeficiency virus type 1 protease,” Phytotherapy Research, vol. 16, no. 5, pp. 422–426, 2002. View at Publisher · View at Google Scholar · View at Scopus
  50. T. Akihisa, H. Tokuda, M. Ukiya et al., “3-Epicabraleahydroxylactone and other triterpenoids from camellia oil and their inhibitory effects on epstein-barr virus activation,” Chemical and Pharmaceutical Bulletin, vol. 52, no. 1, pp. 153–156, 2004. View at Publisher · View at Google Scholar · View at Scopus
  51. D. Miura, Y. Kida, and H. Nojima, “Camellia oil and its distillate fractions effectively inhibit the spontaneous metastasis of mouse melanoma BL6 cells,” FEBS Letters, vol. 581, no. 13, pp. 2541–2548, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. K. Onodera, K. Hanashiro, and T. Yasumoto, “Camellianoside, a novel antioxidant glycoside from the leaves of Camellia japonica,” Bioscience, Biotechnology and Biochemistry, vol. 70, no. 8, pp. 1995–1998, 2006. View at Publisher · View at Google Scholar · View at Scopus
  53. M. J. Piao, E. S. Yoo, Y. S. Koh et al., “Antioxidant effects of the ethanol extract from flower of Camellia japonica via scavenging of reactive oxygen species and induction of antioxidant enzymes,” International Journal of Molecular Science, vol. 12, no. 4, pp. 2618–2630, 2011. View at Publisher · View at Google Scholar
  54. E. Jung, J. Lee, J. Baek et al., “Effect of Camellia japonica oil on human type I procollagen production and skin barrier function,” Journal of Ethnopharmacology, vol. 112, no. 1, pp. 127–131, 2007. View at Publisher · View at Google Scholar · View at Scopus
  55. J.-H. Lee, J.-W. Kim, N.-Y. Ko et al., “Camellia japonica suppresses immunoglobulin E-mediated allergic response by the inhibition of Syk kinase activation in mast cells,” Clinical and Experimental Allergy, vol. 38, no. 5, pp. 794–804, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. H. Itokawa, H. Nakajima, A. Ikuta, and Y. Iitaka, “Two triterpenes from the flowers of Camellia japonica,” Phytochemistry, vol. 20, no. 11, pp. 2539–2542, 1981. View at Google Scholar · View at Scopus
  57. N. T. P. Thao, T. M. Hung, T. D. Cuong et al., “28-Nor-oleanane-type triterpene saponins from Camellia japonica and their inhibitory activity on LPS-induced NO production in macrophage RAW264.7 cells,” Bioorganic and Medicinal Chemistry Letters, vol. 20, no. 24, pp. 7435–7439, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. Jiangsu New Medical College, The Chinese Medicine Dictionary, Shanghai People's Publishing House, Shanghai, China, 1977.
  59. I. Kubo, T. Kamikawa, and T. Kubota, “Studies on constituents of Isodon japonicus Hara. The structures and absolute stereochemistry of isodonal, trichodonin and epinodosin,” Tetrahedron, vol. 30, no. 5, pp. 615–622, 1974. View at Publisher · View at Google Scholar · View at Scopus
  60. T. Kubota and I. Kubo, “A new bitter principle of Isodon japonicus hara,” Tetrahedron Letters, vol. 8, no. 38, pp. 3781–3784, 1967. View at Google Scholar · View at Scopus
  61. E. Fujita, T. Fujita, M. Taoka, H. Katayama, and M. Shibuya, “The structure and absolute configuration of sodoponin and epinodosinol, new minor diterpenoids of Isodon japonicus,” Tetrahedron Letters, vol. 11, no. 6, pp. 421–424, 1970. View at Google Scholar · View at Scopus
  62. L. Wang, X. Q. Zhang, Z. Q. Yin, Y. Wang, and W. Ye, “Two new amaryllidaceae alkaloids from the bulbs of Lycoris radiata,” Chemical and Pharmaceutical Bulletin, vol. 57, no. 6, pp. 610–611, 2009. View at Publisher · View at Google Scholar · View at Scopus
  63. L. Wang, Z. Q. Yin, Y. Cai, X. Zhang, X. Yao, and W. Ye, “Amaryllidaceae alkaloids from the bulbs of Lycoris radiata,” Biochemical Systematics and Ecology, vol. 38, no. 3, pp. 444–446, 2010. View at Publisher · View at Google Scholar · View at Scopus
  64. S. Sancheti, S. Sancheti, S. Lee, J. Lee, and S. Seo, “Screening of korean medicinal plant extracts for α-glucosidase inhibitory activities,” Iranian Journal of Pharmaceutical Research, vol. 10, no. 2, pp. 261–264, 2011. View at Google Scholar · View at Scopus
  65. S. Sancheti, S. Sancheti, B.-H. Um, and S.-Y. Seo, “1,2,3,4,6-penta-O-galloyl-β-d-glucose: a cholinesterase inhibitor from Terminalia chebula,” South African Journal of Botany, vol. 76, no. 2, pp. 285–288, 2010. View at Publisher · View at Google Scholar · View at Scopus
  66. Z. L. Chen, “The history of bayberries,” Journal of Fruit Science, vol. 13, pp. 59–61, 1996. View at Google Scholar
  67. J. Bao, Y. Cai, M. Sun, G. Wang, and H. Corke, “Anthocyanins, flavonols, and free radical scavenging activity of Chinese Bayberry (Myrica rubra) extracts and their color properties and stability,” Journal of Agricultural and Food Chemistry, vol. 53, no. 6, pp. 2327–2332, 2005. View at Publisher · View at Google Scholar · View at Scopus
  68. K. Mochida, “Anti-influenza virus activity of Myrica rubra leaf ethanol extract evaluated using Madino-Darby canine kidney (MDCK) cells,” Bioscience, Biotechnology and Biochemistry, vol. 72, no. 11, pp. 3018–3020, 2008. View at Publisher · View at Google Scholar · View at Scopus
  69. N. Sakurai, Y. Yaguchi, T. Hirakawa, M. Nagai, and T. Inoue, “Two myricanol glycosides from Myrica rubra and revision of the structure of isomyricanone,” Phytochemistry, vol. 30, no. 9, pp. 3077–3079, 1991. View at Google Scholar · View at Scopus
  70. F. Daayf, A. Schmitt, and R. R. Bélanger, “Evidence of phytoalexins in cucumber leaves infected with powdery mildew following treatment with leaf extracts of Reynoutria sachalinensis,” Plant Physiology, vol. 113, no. 3, pp. 719–727, 1997. View at Google Scholar · View at Scopus
  71. S. K. Chung, Y. C. Kim, Y. Takaya, K. Terashima, and M. Niwa, “Novel flavonol glycoside, 7-O-methyl mearnsitrin, from Sageretia theezans and its antioxidant effect,” Journal of Agricultural and Food Chemistry, vol. 52, no. 15, pp. 4664–4668, 2004. View at Publisher · View at Google Scholar · View at Scopus
  72. S. K. Chung, C.-Y. O. Chen, and J. B. Blumberg, “Flavonoid-rich fraction from Sageretia theezans leaves scavenges reactive oxygen radical species and increases the resistance of low-density lipoprotein to oxidation,” Journal of Medicinal Food, vol. 12, no. 6, pp. 1310–1315, 2009. View at Publisher · View at Google Scholar · View at Scopus
  73. H. Bae, R. Kim, Y. Kim et al., “Effects of Schisandra chinensis Baillon (Schizandraceae) on lipopolysaccharide induced lung inflammation in mice,” Journal of Ethnopharmacology, vol. 142, no. 1, pp. 41–47, 2012. View at Publisher · View at Google Scholar · View at Scopus
  74. M. Zhang, Y. Cao, F. L. Du, W. Ou-Yang, and Y. Yuan, “Isolation and identification of two new diterpenoid from Rubus corchorifolius L. f,” Yaoxue Xuebao, vol. 42, no. 11, pp. 1155–1158, 2007. View at Google Scholar · View at Scopus
  75. D. K. Kim and O. P. Zee, “A new cyanogenic glycoside from Sorbaria sorbifolia var. stellipila,” Chemical and Pharmaceutical Bulletin, vol. 48, no. 11, pp. 1766–1767, 2000. View at Google Scholar · View at Scopus
  76. X. Li, L. Wu, X. Zang, and J. Zheng, “Studies on chemical constituents of Sorbaria sorbifolia,” Zhongguo Zhongyao Zazhi, vol. 27, no. 11, pp. 842–843, 2002. View at Google Scholar · View at Scopus
  77. X. Zhang, Y. Zhang, L. Guan, Y. Quan, and Q. Sun, “Study on extraction and isolation of active constituents from Sorbaria sorbifolia and antitumor effect of the constituents in vivo,” Journal of Chinese Medicinal Materials, vol. 27, no. 1, pp. 36–38, 2004. View at Google Scholar · View at Scopus
  78. W. Li, B. Li, and Y. Chen, “Flexuosol A, a new tetrastilbene from Vitis flexuosa,” Journal of Natural Products, vol. 61, no. 5, pp. 646–647, 1998. View at Publisher · View at Google Scholar · View at Scopus